24 May 2013
Keywords: emea, accepts, genta, ma, genasense, new, jersey
Article | 06 February 2006
New Jersey, USA-based biotechnology company Genta says that it has received notice from the European Medicines Agency (EMEA) that its
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 February 2006
27 February 2006
23 May 2013
© 2013 thepharmaletter.com